Epigenetics of hypertension as a risk factor for the development of coronary artery disease in type 2 diabetes mellitus

被引:3
|
作者
Karabaeva, Raushan Zh [1 ]
Vochshenkova, Tamara A. [1 ]
Mussin, Nadiar M. [2 ]
Albayev, Rustam K. [1 ]
Kaliyev, Asset A. [2 ]
Tamadon, Amin [3 ,4 ]
机构
[1] Presidents Affairs Adm Republ Kazakhstan, Med Ctr Hosp, Gerontol Ctr, Astana, Kazakhstan
[2] West Kazakhstan Marat Ospanov Med Univ, Gen Surg, Aktobe, Kazakhstan
[3] West Kazakhstan Marat Ospanov Med Univ, Dept Nat Sci, Aktobe, Kazakhstan
[4] PerciaVista R&D Co, Dept Res & Dev, Shiraz, Iran
来源
FRONTIERS IN ENDOCRINOLOGY | 2024年 / 15卷
关键词
coronary artery disease; hypertension; type 2 diabetes mellitus; epigenetics; genetic variation; DNA methylation; histone; modification; DNA METHYLATION; BLOOD-PRESSURE; CARDIAC-HYPERTROPHY; LIFE-STYLE; GENE; MODULATION; EXPRESSION; SALT; PREECLAMPSIA; DEFICIENCY;
D O I
10.3389/fendo.2024.1365738
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hypertension, a multifaceted cardiovascular disorder influenced by genetic, epigenetic, and environmental factors, poses a significant risk for the development of coronary artery disease (CAD) in individuals with type 2 diabetes mellitus (T2DM). Epigenetic alterations, particularly in histone modifications, DNA methylation, and microRNAs, play a pivotal role in unraveling the complex molecular underpinnings of blood pressure regulation. This review emphasizes the crucial interplay between epigenetic attributes and hypertension, shedding light on the prominence of DNA methylation, both globally and at the gene-specific level, in essential hypertension. Additionally, histone modifications, including acetylation and methylation, emerge as essential epigenetic markers linked to hypertension. Furthermore, microRNAs exert regulatory influence on blood pressure homeostasis, targeting key genes within the aldosterone and renin-angiotensin pathways. Understanding the intricate crosstalk between genetics and epigenetics in hypertension is particularly pertinent in the context of its interaction with T2DM, where hypertension serves as a notable risk factor for the development of CAD. These findings not only contribute to the comprehensive elucidation of essential hypertension but also offer promising avenues for innovative strategies in the prevention and treatment of cardiovascular complications, especially in the context of T2DM.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Associations of Insomnia With Hypertension and Coronary Artery Disease Among Patients With Type 2 Diabetes Mellitus
    Hu, Yonghui
    Yan, Zhiyue
    Fu, Zhenrui
    Pan, Congqing
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [2] High Risk for the Development of Type 2 Diabetes Mellitus in Patients With Coronary Artery Disease
    Saely, Christoph H.
    Vonbank, Alexander
    Rein, Philipp
    Drexel, Heinz
    CIRCULATION, 2013, 127 (12)
  • [3] Clinical relevance of epigenetics in the onset and management of type 2 diabetes mellitus
    Sommese, Linda
    Zullo, Alberto
    Mancini, Francesco Paolo
    Fabbricini, Rossella
    Soricelli, Andrea
    Napoli, Claudio
    EPIGENETICS, 2017, 12 (06) : 401 - 415
  • [4] Prevalence of type 2 diabetes mellitus and risk of hypertension and coronary artery disease in rural and urban population with low rates of obesity
    Singh, RB
    Bajaj, S
    Niaz, MA
    Rastogi, SS
    Moshiri, M
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 1998, 66 (01) : 65 - 72
  • [5] Type 2 diabetes mellitus is a risk factor for the development of hypertension in postmenopausal women
    Rossi, Rosario
    Turco, Vincenzo
    Origliani, Giorgia
    Modena, M. Grazia
    JOURNAL OF HYPERTENSION, 2006, 24 (10) : 2017 - 2022
  • [6] Genetic Predisposition to Coronary Artery Disease in Type 2 Diabetes Mellitus
    van Zuydam, Natalie R.
    Ladenvall, Claes
    Voight, Benjamin F.
    Strawbridge, Rona J.
    Fernandez-Tajes, Juan
    Rayner, N. William
    Robertson, Neil R.
    Mahajan, Anubha
    Vlachopoulou, Efthymia
    Goel, Anuj
    Kleber, Marcus E.
    Nelson, Christopher P.
    Kwee, Lydia Coulter
    Esko, Tonu
    Mihailov, Evelin
    Magi, Reedik
    Milani, Lili
    Fischer, Krista
    Kanoni, Stavroula
    Kumar, Jitender
    Song, Ci
    Hartiala, Jaana A.
    Pedersen, Nancy L.
    Perola, Markus
    Gieger, Christian
    Peters, Annette
    Qu, Liming
    Willems, Sara M.
    Doney, Alex S. F.
    Morris, Andrew D.
    Zheng, Yan
    Sesti, Giorgio
    Hu, Frank B.
    Qi, Lu
    Laakso, Markku
    Thorsteinsdottir, Unnur
    Grallert, Harald
    van Duijn, Cornelia
    Reilly, Muredach P.
    Ingelsson, Erik
    Deloukas, Panos
    Kathiresan, Sek
    Metspalu, Andres
    Shah, Svati H.
    Sinisalo, Juha
    Salomaa, Veikko
    Hamsten, Anders
    Samani, Nilesh J.
    Maerz, Winfried
    Hazen, Stanley L.
    CIRCULATION-GENOMIC AND PRECISION MEDICINE, 2020, 13 (06): : 640 - 648
  • [7] Apparent therapy-resistant hypertension as risk factor for the development of type 2 diabetes mellitus
    Holtrop, Joris
    Spiering, Wilko
    Nathoe, Hendrik M.
    De Borst, Gert J.
    Kappelle, Laurens J.
    De Valk, Harold W.
    Visseren, Frank L. J.
    Westerink, Jan
    JOURNAL OF HYPERTENSION, 2020, 38 (01) : 45 - 51
  • [8] Epigenetics-by-Sex Interaction for Coronary Artery Disease Risk Conferred by the Cystathionine γ-Lyase Gene Promoter Methylation
    Giannakopoulou, Efstathia
    Konstantinou, Fotios
    Ragia, Georgia
    Tavridou, Anna
    Karaglani, Makrina
    Chatzaki, Ekaterini
    Papapetropoulos, Andreas
    Mikroulis, Dimitrios
    Manolopoulos, Vangelis G.
    OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY, 2017, 21 (12) : 741 - 748
  • [9] Passive Myocardial Tension in Patients With Hypertension, Type 2 Diabetes Mellitus and Coronary Artery Disease
    Donaldson, Cameron
    Palmer, Bradley
    Zile, Michael
    Ashikaga, Takamaru
    Meyer, Markus
    VanBuren, Peter
    Spinale, Francis
    Maughan, David
    Redfield, Margaret
    Bull, David
    LeWinter, Martin
    CIRCULATION, 2011, 124 (21)
  • [10] Transcriptional profiles associated with coronary artery disease in type 2 diabetes mellitus
    Nevado Jr, Jose B.
    de la Paz, Eva Maria C.
    Paz-Pacheco, Elizabeth T.
    Jasul Jr, Gabriel V.
    Aman, Aimee Yvonne Criselle L.
    Deguit, Christian Deo T.
    Pedro, Jana Victoria B. San
    Francisco, Mark David G.
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15